Inventor · disambiguated record
Florence Fevrier Wagner
Also filed as: WAGNER FLORENCE · WAGNER FLORENCE F · WAGNER FLORENCE FEVRIER
37 granted patents·17 pending applications·123 citations·filing 2007–2025
97Inventor score
Top patents by PatentIndex Score
54 records- 0196US11414423B1Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disordersUNIV CALIFORNIA·Filed 2021·Granted Aug 16, 2022·8 cites·28 claims
- 0293US10662199B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2017·Granted May 26, 2020·3 cites·39 claims
- 0392US9890172B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2016·Granted Feb 13, 2018·10 cites·28 claims
- 0491US11254640B2N-substituted indoles and other heterocycles for treating brain disordersUNIV CALIFORNIA·Filed 2021·Granted Feb 22, 2022·4 cites·25 claims
- 0591US9447030B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2013·Granted Sep 20, 2016·13 cites·22 claims
- 0691US9365498B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2013·Granted Jun 14, 2016·13 cites·22 claims
- 0790US9314468B2Chemokine receptor modulatorsALTIRIS THERAPEUTICS INC·Filed 2012·Granted Apr 19, 2016·21 cites·8 claims
- 0888US11207278B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Dec 28, 2021·2 cites·20 claims
- 0988US10137122B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2015·Granted Nov 27, 2018·8 cites·66 claims
- 1087US9096594B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2013·Granted Aug 4, 2015·9 cites·22 claims
- 1184US10793538B2Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitorsBROAD INST INC·Filed 2018·Granted Oct 6, 2020·3 cites·20 claims
- 1283US11052080B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2018·Granted Jul 6, 2021·3 cites·31 claims
- 1381US11572368B2Inhibitors of histone deacetylaseMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Feb 7, 2023·1 cites·38 claims
- 1481US11498896B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2020·Granted Nov 15, 2022·1 cites·32 claims
- 1581US11203601B2Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereofBROAD INST INC·Filed 2018·Granted Dec 21, 2021·2 cites·41 claims
- 1681US9790184B2Inhibitors of histone deacetylaseMASSACHUSETTS GEN HOSPITAL·Filed 2013·Granted Oct 17, 2017·6 cites·25 claims
- 1780US10633336B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2015·Granted Apr 28, 2020·2 cites·22 claims
- 1879US9914717B2Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitorsBROAD INST INC·Filed 2013·Granted Mar 13, 2018·5 cites·28 claims
- 1979US8338448B2Chemokine receptor modulatorsCLARK MICHAEL P·Filed 2009·Granted Dec 25, 2012·5 cites·11 claims
- 2076US12295959B2Phenoxy and benzyloxy substituted psychoplastogens and uses thereofDELIX THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 2176US11377423B2Inhibitors of histone deacetylaseBROAD INST INC·Filed 2017·Granted Jul 5, 2022·2 cites·91 claims
- 2274US12428373B2Dopamine D2 receptor ligandsBROAD INST INC·Filed 2022·Granted Sep 30, 2025·0 cites·37 claims
- 2372US12419885B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2021·Granted Sep 23, 2025·0 cites·42 claims
- 2472US12048676B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Jul 30, 2024·0 cites·22 claims
- 2572US12023308B2Agents for reversing toxic proteinopathiesBROAD INST INC·Filed 2021·Granted Jul 2, 2024·0 cites·17 claims
- 2671US9856509B2Fluorescent substrates for determining lysine modifying enzyme activityBROAD INST INC·Filed 2014·Granted Jan 2, 2018·1 cites·29 claims
- 2769US12325710B2Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disordersUNIV CALIFORNIA·Filed 2022·Granted Jun 10, 2025·0 cites·18 claims
- 2869US8729130B2Methods of using novel solid forms of tacedinalineHOLSON EDWARD·Filed 2012·Granted May 20, 2014·1 cites·7 claims
- 2965US2024269129A1Glycogen synthase kinase 3 (gsk3) inhibitors for treating ctnnb1 syndromeTUFTS COLLEGE·Filed 2024·Application pending·0 cites
- 3064US10626438B2Fluorescent substrates for determining lysine modifying enzyme activityBROAD INST INC·Filed 2017·Granted Apr 21, 2020·0 cites·22 claims
- 3164US9266822B2Solid forms of tacedinalineBROAD INST INC·Filed 2014·Granted Feb 23, 2016·0 cites·4 claims
- 3262US12486289B2Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereofBROAD INST INC·Filed 2021·Granted Dec 2, 2025·0 cites·31 claims
- 3362US11840495B2Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compoundsBROAD INST INC·Filed 2021·Granted Dec 12, 2023·0 cites·16 claims
- 3460US2025235463A1Phenoxy and benzyloxy substituted psychoplastogens and uses thereofDELIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3560US2022251040A1N-substituted indoles and other heterocycles for treating brain disordersUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 3659US7820826B2Synthesis and regioselective substitution of 6-halo-and 6-alkoxy nicotine derivativesUNIV NORTH CAROLINA STATE·Filed 2007·Granted Oct 26, 2010·0 cites·22 claims
- 3758US8691875B2Solid forms of tacedinalineHOLSON EDWARD·Filed 2012·Granted Apr 8, 2014·0 cites·4 claims
- 3855US2024116850A1Compositions and methods related to bicyclo[2.2.1] heptanamine-containing compoundsBROAD INST INC·Filed 2021·Application pending·0 cites
- 3955US2025179065A1Hdac6 inhibitors and uses thereofEIKONIZO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4054US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 4153US2013131015A1Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivativesUNIV NORTH CAROLINA STATE·Filed 2013·Application pending·0 cites
- 4252US2012101147A1Inhibition of hdac2 to promote memoryTSAI LI-HUEI·Filed 2009·Application pending·0 cites
- 4351US2024174616A1Hdac6 inhibitors and uses thereofEIKONIZO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4450US8841346B2Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disordersTSAI LI-HUEI·Filed 2012·Granted Sep 23, 2014·0 cites·16 claims
- 4550US2023295106A1Ergoline-like compounds for promoting neural plasticityUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4649US2023219969A1Isotryptamine psychoplastogens and uses thereofDELIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4749US2023227453A1Tricyclic psychoplastogens and uses thereofDELIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4846US8563615B2Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disordersTSAI LI-HUEI·Filed 2010·Granted Oct 22, 2013·0 cites·10 claims
- 4945US2008293711A1Chemokine receptor modulatorsCLARK MICHAEL P·Filed 2008·Application pending·0 cites
- 5045US2025313563A1Glycogen synthase kinase 3 inhibitors and uses thereofBROAD INST INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →